Treatment
angiotensin-converting enzyme
ACE
inhibitors
reduces
mortality
morbidity
patients
chronic heart failure
CHF
affected
patients
agents
treated with
doses
efficacious
trials
concerns
safety
tolerability
agents
recommended doses
study
safety
tolerability
compared
low-dose lisinopril
CHF
